Holen Sie sich die Stockscreener-App
1.60
1.91%
0.03
Handel nachbörslich:
1.59
-0.01
-0.63%
Schlusskurs vom Vortag:
$1.57
Offen:
$1.57
24-Stunden-Volumen:
320.69K
Relative Volume:
0.38
Marktkapitalisierung:
$118.23M
Einnahmen:
$311.14M
Nettoeinkommen (Verlust:
$-177.97M
KGV:
-0.6317
EPS:
-2.5329
Netto-Cashflow:
$-20.82M
1W Leistung:
+19.40%
1M Leistung:
+36.75%
6M Leistung:
-47.54%
1J Leistung:
-60.69%
1-Tages-Spanne:
$1.49
$1.62
1-Wochen-Bereich:
$1.21
$1.77
52-Wochen-Spanne:
$0.9551
$5.062
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.60 | 116.01M | 311.14M | -177.97M | -20.82M | -2.5329 |
VEEV
Veeva Systems Inc
|
171.19 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
51.44 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.07 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.63 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.77 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
3 Reasons to Avoid HCAT and 1 Stock to Buy Instead - Yahoo Finance
[Form 4] Health Catalyst, Inc. Insider Trading Activity - Stock Titan
Health Catalyst (NASDAQ: HCAT) director Nelson submits initial Form 3 - Stock Titan
MSN Money - MSN
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
8x8, Veeva Systems, and Health Catalyst Shares Are Soaring, What You Need To Know - Yahoo Finance
Health Catalyst | 4: Statement of changes in beneficial ownership of securities-Officer Albert Benjamin - Moomoo
Health Catalyst (NASDAQ: HCAT) restricted stock sale notice by affiliate - Stock Titan
Health Catalyst (HCAT) CEO receives PRSUs, sells shares to cover taxes - Stock Titan
Health Catalyst 2025 Executive Compensation: Pay-for-Performance Philosophy, Metrics, and Practices Explained - Minichart
Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026 - The Manila Times
Health Catalyst to post quarterly results after the close on May 11 - Stock Titan
Health Catalyst Inc expected to post earnings of 2 cents a shareEarnings Preview - TradingView
Health Catalyst | 10-K/A: Annual report (Amendment) - Moomoo
Executive pay and leadership shifts at Health Catalyst (NASDAQ: HCAT) - Stock Titan
Health Catalyst Adds Steve Nelson to Board of Directors - TipRanks
Health Catalyst | 8-K: Current report - Moomoo
Health Catalyst adds Aetna executive to board of directors - Investing.com
Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors - The Manila Times
Health Catalyst adds Aetna executive to board of directors By Investing.com - Investing.com UK
Health Catalyst Appoints Steve Nelson to Board of Directors to Strengthen Leadership in Healthcare Intelligence - Quiver Quantitative
Aetna president joins Health Catalyst board after CEO, chair changes - Stock Titan
Aetna president Steve Nelson joins Health Catalyst (HCAT) board amid leadership refresh - Stock Titan
Winners And Losers Of Q4: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks - Barchart
Health Catalyst (HCAT) to Release Quarterly Earnings on Wednesday - MarketBeat
Health Catalyst (HCAT) price target decreased by 45.97% to 2.14 - MSN
Health Catalyst down as Piper Sandler adds to downgrades on Q2 results - MSN
HCAT Announces Workforce Reduction as Part of Strategic Overhaul - GuruFocus
Health Catalyst (HCAT) Announces Changes to Executive Leadership - GuruFocus
Health Catalyst Inc board authorizes workforce reduction on April 24, 2026 under Project Nexus - marketscreener.com
According to the latest filing disclosed by the U.S. Securities and Exchange Commission, Health Catalyst, Inc. announced a change in position for its Chief People Officer, Linda Llewelyn. - Bitget
Health Catalyst Announces Restructuring and Workforce Reduction Plan - TipRanks
Project Nexus: Health Catalyst (NASDAQ: HCAT) trims workforce and reshapes roles - Stock Titan
Ambulatory Control: The Growth Engine Under Pressure - Modern Healthcare
Q4 2024 Health Catalyst Inc Earnings Call Transcript - GuruFocus
Health Catalyst (HCAT) may find a bottom soon, here's why you should buy the stock now - MSN
Health Catalyst (HCAT) Stock Pending Order (Volatility Increases) 2026-04-22Open Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
HCAT Financials: Income Statement, Balance Sheet & Cash Flow | Health Catalyst - Stock Titan
HCAT Forecast, Price Target & Analyst Ratings | HEALTH CATALYST INC (NASDAQ:HCAT) - ChartMill
Citigroup Maintains Health Catalyst (HCAT) Neutral Recommendation - MSN
Health Catalyst (HCAT) Stock: Is It Trading at Premium (Risk Aversion) 2026-04-20Momentum Picks - Cổng thông tin điện tử Tỉnh Sơn La
How does market volatility impact Health Catalyst (HCAT) stock (Gains) 2026-04-18High Beta Stocks - Xã Thanh Hà
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a 59.7% Potential Upside Amidst Challenging Performance Metrics - DirectorsTalk Interviews
Health Catalyst and ZoomInfo Stocks Trade Up, What You Need To Know - Yahoo Finance
HCAT Rating Maintained as Citigroup Lowers Price Target | HCAT S - GuruFocus
Health Catalyst (HCAT) Stock: Summer Outlook (Rockets) 2026-04-15Crowd Trend Signals - UBND thành phố Hải Phòng
Global Patient Engagement Solutions Market to Grow by - GlobeNewswire
Global Patient Engagement Solutions Market to Grow by $21.76 Billion Through 2030McKesson, Veradigm, Oracle, Athenahealth, and Health Catalyst Dominate - Yahoo Finance
Health Catalyst, Commerce, DocuSign, Unity, and Workiva Shares Plummet, What You Need To Know - Yahoo Finance
Health Catalyst, Inc. (HCAT) cut to equal weight at Wells Fargo on prolonged revenue, margin pressure - MSN
Doximity, Guidewire Software, Intuit, PagerDuty, and Health Catalyst Shares Plummet, What You Need To Know - Yahoo Finance
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.66%
1.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):